Artemis Investment Management’s Veracyte VCYT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-10,050
Closed -$223K 243
2024
Q1
$223K Sell
10,050
-6,342
-39% -$155K ﹤0.01% 212
2023
Q4
$451K Sell
16,392
-395
-2% -$9.54K 0.01% 202
2023
Q3
$375K Buy
16,787
+4,536
+37% +$117K 0.01% 198
2023
Q2
$312K Sell
12,251
-1,228
-9% -$29.8K ﹤0.01% 202
2023
Q1
$300K Sell
13,479
-2,413
-15% -$58.3K ﹤0.01% 209
2022
Q4
$378K Sell
15,892
-3,099
-16% -$72K ﹤0.01% 217
2022
Q3
$315K Sell
18,991
-13,942
-42% -$314K ﹤0.01% 224
2022
Q2
$656K Sell
32,933
-10,218
-24% -$206K 0.01% 223
2022
Q1
$1.19M Buy
43,151
+4,169
+11% +$119K 0.01% 246
2021
Q4
$1.6M Buy
38,982
+6,934
+22% +$306K 0.01% 250
2021
Q3
$1.49M Buy
32,048
+7,811
+32% +$341K 0.01% 269
2021
Q2
$970K Buy
+24,237
New +$1.04M 0.01% 274

Other funds holding VCYT

Artemis Investment Management's VCYT Position: Q2 2024 in Review

Artemis Investment Management sold out of Veracyte (VCYT) in Q2 2024, closing a stake of 10,050 shares — an estimated $223K sold.

Artemis Investment Management first reported a position in VCYT in Q2 2021 and held it in 12 quarters. The position peaked at $1.6M in Q4 2021. 240 funds tracked by Wall St. Rank hold VCYT as of Q2 2024.

  • Artemis Investment Management reported no remaining Veracyte position as of Q2 2024 after selling out during the quarter.
  • Artemis Investment Management sold 10,050 Veracyte shares in Q2 2024, an estimated $223K.
  • Artemis Investment Management first reported a position in Veracyte in Q2 2021 and held it in 12 quarters.
  • Artemis Investment Management's Veracyte position peaked at $1.6M in Q4 2021.
  • 240 funds tracked by Wall St. Rank held Veracyte as of Q2 2024.

Based on Artemis Investment Management's 13F filing for Q2 2024, filed 15 Jul 2024.